172 related articles for article (PubMed ID: 27986475)
1. Polymeric nanoparticles - Influence of the glass transition temperature on drug release.
Lappe S; Mulac D; Langer K
Int J Pharm; 2017 Jan; 517(1-2):338-347. PubMed ID: 27986475
[TBL] [Abstract][Full Text] [Related]
2. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.
Sunazuka Y; Ueda K; Higashi K; Wada K; Moribe K
Mol Pharm; 2024 Mar; 21(3):1424-1435. PubMed ID: 38324797
[TBL] [Abstract][Full Text] [Related]
4. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
[TBL] [Abstract][Full Text] [Related]
5. The dispersion releaser technology is an effective method for testing drug release from nanosized drug carriers.
Janas C; Mast MP; Kirsamer L; Angioni C; Gao F; Mäntele W; Dressman J; Wacker MG
Eur J Pharm Biopharm; 2017 Jun; 115():73-83. PubMed ID: 28213179
[TBL] [Abstract][Full Text] [Related]
6. Influence of surfactant on glass transition temperature of poly(lactic-
Liu G; Martinez R; Bhatnagar A; McEnnis K
Soft Matter; 2023 Jul; 19(28):5371-5378. PubMed ID: 37409398
[TBL] [Abstract][Full Text] [Related]
7. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
8. Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior.
Karavelidis V; Giliopoulos D; Karavas E; Bikiaris D
Eur J Pharm Sci; 2010 Dec; 41(5):636-43. PubMed ID: 20863892
[TBL] [Abstract][Full Text] [Related]
9. Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
Keloglu N; Verrier B; Trimaille T; Sohier J
Colloids Surf B Biointerfaces; 2016 Apr; 140():142-149. PubMed ID: 26752211
[TBL] [Abstract][Full Text] [Related]
10. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
11. In vitro release and stereoselective disposition of flurbiprofen loaded to poly(D,L-lactide- co-glycolide) nanoparticles in rats.
Radwan MA; Aboul-Enein HY
Chirality; 2004 Feb; 16(2):119-25. PubMed ID: 14712475
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
13. The mechanism behind the biphasic pulsatile drug release from physically mixed poly(dl-lactic(-co-glycolic) acid)-based compacts.
Beugeling M; Grasmeijer N; Born PA; van der Meulen M; van der Kooij RS; Schwengle K; Baert L; Amssoms K; Frijlink HW; Hinrichs WLJ
Int J Pharm; 2018 Nov; 551(1-2):195-202. PubMed ID: 30223077
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Muntimadugu E; Dhommati R; Jain A; Challa VG; Shaheen M; Khan W
Eur J Pharm Sci; 2016 Sep; 92():224-34. PubMed ID: 27185298
[TBL] [Abstract][Full Text] [Related]
15. Thermodynamic phase behaviour of indomethacin/PLGA formulations.
Prudic A; Lesniak AK; Ji Y; Sadowski G
Eur J Pharm Biopharm; 2015 Jun; 93():88-94. PubMed ID: 25791211
[TBL] [Abstract][Full Text] [Related]
16. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
17. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
18. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
Narvekar M; Xue HY; Wong HL
Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
20. Drug release behavior of poly (lactic-glycolic acid) grafting from sodium alginate (ALG-g-PLGA) prepared by direct polycondensation.
Shi G; Ding Y; Zhang X; Wu L; He F; Ni C
J Biomater Sci Polym Ed; 2015; 26(16):1152-62. PubMed ID: 26255582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
